Mark L. Fuerst is a freelance health and medical writer for ConsultantLive, Rheumatology Network, Psychiatric Times, and other UBM publications. He writes about rheumatology, psychiatry, neurology, endocrinology, oncology, and men’s health.
Oncologists Reluctant to Give Exercise Recommendations to Cancer Patients
Both oncologists and cancer patients recognize the benefits of physical activity during treatment, but oncologists may feel ill-equipped to give recommendations on exercise, according to a new study.
MEK Inhibitor Adds No Value in Treatment of KRAS-Mutant NSCLC
Adding selumetinib to docetaxel does not provide any significant benefit over docetaxel alone for patients previously treated for advanced KRAS-mutant non–small-cell lung cancer.
Engagement in HIV Care Can Mean Longer Life
Antiretroviral therapy has dramatically reduced AIDS-associated morbidity and mortality -- but only in those who know they are HIV positive and if they maintain sustained engagement with care.
3 Weighty New Issues in Asthma Care
May is Asthma Awareness Month and so a look at new studies highlighting key aspects of management is in order.
PET Imaging May Predict Early Immunotherapy Response
A noninvasive PET imaging method may serve as a useful predictive biomarker for responses to cancer immunotherapy, according to a new study.
Corticosteroids Overprescribed in Young Asthmatics
Prescribing has gone from underuse to substantial overprescribing. The challenge is to get it just right.
Vaccine/Chemotherapy Combination Improves Survival in Glioblastoma
Cytomegalovirus targeted vaccination plus high-dose chemotherapy with temozolomide can lead to long-term progression-free and overall survival in patients with newly diagnosed glioblastoma.
CheckMate 067 Shows OS Improved With Nivolumab/Ipilimumab in Melanoma
A nivolumab/ipilimumab combination significantly improved overall survival for advanced melanoma patients.
Ischemic Stroke and Older AIDS Patients
The paradigm of HIV care is changing for aging patients. This study sheds new light.
Young Obese Men at Risk for Liver Cancer
Young men who are overweight or obese are at risk of developing severe liver disease or liver cancer in later life, particularly those who have type 2 diabetes mellitus.
By clicking Accept, you agree to become a member of the UBM Medica Community.